(Q33486828)
Statements
Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione (English)
Von Hoff DD
Pollard E
Kuhn J
Murray E